E Sung, M Ko, J Won, Y Jo, E Park, H Kim, E Choi… - Molecular Therapy, 2022 - cell.com
Several preclinical studies demonstrate that antitumor efficacy of programmed cell death-1
(PD-1)/programmed death-ligand 1 (PD-L1) blockade can be improved by combination with …